{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:03:15Z","timestamp":1790128995172,"version":"4.0.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,11,4]],"date-time":"2016-11-04T00:00:00Z","timestamp":1478217600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1038\/pr.2016.230","type":"journal-article","created":{"date-parts":[[2016,11,4]],"date-time":"2016-11-04T17:01:51Z","timestamp":1478278911000},"page":"307-314","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Propranolol 0.1% eye micro-drops in newborns with retinopathy of prematurity: a pilot clinical trial"],"prefix":"10.1038","volume":"81","author":[{"given":"Luca","family":"Filippi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Cavallaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Bagnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Dal Monte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizio","family":"Fiorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elettra","family":"Berti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Padrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianpaolo","family":"Donzelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Araimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Cristofori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Fumagalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"la Marca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Della Bona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Pasqualetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pina","family":"Fortunato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Osnaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Tomasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Vanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Calvani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvano","family":"Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Cortinovis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Pugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Agosti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Mosca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,4]]},"reference":[{"key":"BFpr2016230_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/pr.2013.205","volume":"74 Suppl 1","author":"H Blencowe","year":"2013","unstructured":"Blencowe H, Lawn JE, Vazquez T, Fielder A, Gilbert C. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr Res 2013;74 Suppl 1:35\u201349.","journal-title":"Pediatr Res"},{"key":"BFpr2016230_CR2","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1469-8749.1994.tb11853.x","volume":"36","author":"CE Gilbert","year":"1994","unstructured":"Gilbert CE, Canovas R, Kocksch de Canovas R, Foster A. Causes of blindness and severe visual impairment in children in Chile. Dev Med Child Neurol 1994;36:326\u201333.","journal-title":"Dev Med Child Neurol"},{"key":"BFpr2016230_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.earlhumdev.2007.11.009","volume":"84","author":"C Gilbert","year":"2008","unstructured":"Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev 2008;84:77\u201382.","journal-title":"Early Hum Dev"},{"key":"BFpr2016230_CR4","doi-asserted-by":"publisher","first-page":"e518","DOI":"10.1542\/peds.2004-1180","volume":"115","author":"C Gilbert","year":"2005","unstructured":"Gilbert C, Fielder A, Gordillo L, et al.; International NO-ROP Group. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics 2005;115:e518\u201325.","journal-title":"Pediatrics"},{"key":"BFpr2016230_CR5","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1136\/bjophthalmol-2011-300015","volume":"95","author":"LC Zepeda-Romero","year":"2011","unstructured":"Zepeda-Romero LC, Barrera-de-Leon JC, Camacho-Choza C, et al. Retinopathy of prematurity as a major cause of severe visual impairment and blindness in children in schools for the blind in Guadalajara city, Mexico. Br J Ophthalmol 2011;95:1502\u20135.","journal-title":"Br J Ophthalmol"},{"key":"BFpr2016230_CR6","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","volume":"380","author":"T Vos","year":"2012","unstructured":"Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2163\u201396.","journal-title":"Lancet"},{"key":"BFpr2016230_CR7","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/eye.2009.306","volume":"24","author":"A Scott","year":"2010","unstructured":"Scott A, Fruttiger M. Oxygen-induced retinopathy: a model for vascular pathology in the retina. Eye (Lond) 2010;24:416\u201321.","journal-title":"Eye (Lond)"},{"key":"BFpr2016230_CR8","first-page":"101","volume":"35","author":"LE Smith","year":"1994","unstructured":"Smith LE, Wesolowski E, McLellan A, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 1994;35:101\u201311.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFpr2016230_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10456-007-9066-0","volume":"10","author":"J Chen","year":"2007","unstructured":"Chen J, Smith LE. Retinopathy of prematurity. Angiogenesis 2007;10:133\u201340.","journal-title":"Angiogenesis"},{"key":"BFpr2016230_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1167\/iovs.10-5536","volume":"52","author":"C Ristori","year":"2011","unstructured":"Ristori C, Filippi L, Dal Monte M, et al. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade. Invest Ophthalmol Vis Sci 2011;52:155\u201370.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFpr2016230_CR11","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1167\/iovs.11-9408","volume":"53","author":"M Dal Monte","year":"2012","unstructured":"Dal Monte M, Martini D, Latina V, Pavan B, Filippi L, Bagnoli P. Beta-adrenoreceptor agonism influences retinal responses to hypoxia in a model of retinopathy of prematurity. Invest Ophthalmol Vis Sci 2012;53:2181\u201392.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFpr2016230_CR12","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1111\/j.1471-4159.2011.07530.x","volume":"119","author":"D Martini","year":"2011","unstructured":"Martini D, Monte MD, Ristori C, et al. Antiangiogenic effects of \u03b22-adrenergic receptor blockade in a mouse model of oxygen-induced retinopathy. J Neurochem 2011;119:1317\u201329.","journal-title":"J Neurochem"},{"key":"BFpr2016230_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1167\/iovs.14-15263","volume":"56","author":"M Dal Monte","year":"2014","unstructured":"Dal Monte M, Cammalleri M, Mattei E, Filippi L, Bagnoli P. Protective effects of \u03b21\/2 adrenergic receptor deletion in a model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 2014;56:59\u201373.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFpr2016230_CR14","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1167\/iovs.12-9691","volume":"53","author":"J Chen","year":"2012","unstructured":"Chen J, Joyal JS, Hatton CJ, et al. Propranolol inhibition of \u03b2-adrenergic receptor does not suppress pathologic neovascularization in oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 2012;53:2968\u201377.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFpr2016230_CR15","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/labinvest.3700277","volume":"85","author":"CK Chan","year":"2005","unstructured":"Chan CK, Pham LN, Zhou J, Spee C, Ryan SJ, Hinton DR. Differential expression of pro- and antiangiogenic factors in mouse strain-dependent hypoxia-induced retinal neovascularization. Lab Invest 2005;85:721\u201333.","journal-title":"Lab Invest"},{"key":"BFpr2016230_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00210-003-0860-y","volume":"369","author":"C Hoffmann","year":"2004","unstructured":"Hoffmann C, Leitz MR, Oberdorf-Maass S, Lohse MJ, Klotz KN. Comparative pharmacology of human beta-adrenergic receptor subtypes\u2013characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch Pharmacol 2004;369:151\u20139.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"BFpr2016230_CR17","doi-asserted-by":"publisher","first-page":"7421","DOI":"10.1167\/iovs.12-10721","volume":"53","author":"L Filippi","year":"2012","unstructured":"Filippi L, Dal Monte M, Bagnoli P. Different efficacy of propranolol in mice with oxygen-induced retinopathy: could differential effects of propranolol be related to differences in mouse strains? Invest Ophthalmol Vis Sci 2012;53:7421\u20133.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFpr2016230_CR18","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00246-005-1126-x","volume":"27","author":"KK Wong","year":"2006","unstructured":"Wong KK, Potts JE, Etheridge SP, Sanatani S. Medications used to manage supraventricular tachycardia in the infant a North American survey. Pediatr Cardiol 2006;27:199\u2013203.","journal-title":"Pediatr Cardiol"},{"key":"BFpr2016230_CR19","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1046\/j.1365-2265.2001.01173.x","volume":"54","author":"C Smith","year":"2001","unstructured":"Smith C, Thomsett M, Choong C, Rodda C, McIntyre HD, Cotterill AM. Congenital thyrotoxicosis in premature infants. Clin Endocrinol (Oxf) 2001;54:371\u20136.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BFpr2016230_CR20","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1097\/MOP.0b013e32832ff3a7","volume":"21","author":"EH Garin","year":"2009","unstructured":"Garin EH, Araya CE. Treatment of systemic hypertension in children and adolescents. Curr Opin Pediatr 2009;21:600\u20134.","journal-title":"Curr Opin Pediatr"},{"key":"BFpr2016230_CR21","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1510\/icvts.2007.160945","volume":"7","author":"AB Mahmoud","year":"2008","unstructured":"Mahmoud AB, Tantawy AE, Kouatli AA, Baslaim GM. Propranolol: a new indication for an old drug in preventing postoperative junctional ectopic tachycardia after surgical repair of tetralogy of Fallot. Interact Cardiovasc Thorac Surg 2008;7:184\u20137.","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"BFpr2016230_CR22","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1016\/j.jpeds.2013.07.049","volume":"163","author":"L Filippi","year":"2013","unstructured":"Filippi L, Cavallaro G, Bagnoli P, et al. Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives. J Pediatr 2013;163:1570\u20131577.e6.","journal-title":"J Pediatr"},{"key":"BFpr2016230_CR23","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/archopht.123.7.991","volume":"123","author":"International Committee for the Classification of Retinopathy of Prematurity.","year":"2005","unstructured":"International Committee for the Classification of Retinopathy of Prematurity. The International Classification of the Retinopathy of Prematurity revisited. Arch Ophthalmol 2005; 123:991\u20139.","journal-title":"Arch Ophthalmol"},{"key":"BFpr2016230_CR24","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/archdischild-2013-303951","volume":"98","author":"IR Makhoul","year":"2013","unstructured":"Makhoul IR, Peleg O, Miller B, et al. Oral propranolol vs placebo for retinopathy of prematurity: a pilot, randomised, double-blind prospective study. Arch Dis Child 2013;98:565\u20137.","journal-title":"Arch Dis Child"},{"key":"BFpr2016230_CR25","doi-asserted-by":"crossref","unstructured":"Bancalari A, Schade R, Mu\u00f1oz T, Lazcano C, Parada R, Pe\u00f1a R . Oral propranolol in early stages of retinopathy of prematurity. J Perinat Med 2016 Jul 1;44(5):499\u2013503.","DOI":"10.1515\/jpm-2015-0357"},{"key":"BFpr2016230_CR26","doi-asserted-by":"crossref","unstructured":"Korkmaz L, Ba\u015ftu\u011f O, Ozdemir A, Korkut S, Karaca C, Akin MA, Gunes T, Kurtoglu S, Ozturk MA . The Efficacy of Propranolol in Retinopathy of Prematurity and its Correlation with the Platelet Mass Index. Curr Eye Res. 2016 Jun 3:1\u201310.","DOI":"10.3109\/02713683.2016.1158272"},{"key":"BFpr2016230_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.exer.2013.03.013","volume":"111","author":"M Dal Monte","year":"2013","unstructured":"Dal Monte M, Casini G, la Marca G, Isacchi B, Filippi L, Bagnoli P. Eye drop propranolol administration promotes the recovery of oxygen-induced retinopathy in mice. Exp Eye Res 2013;111:27\u201335.","journal-title":"Exp Eye Res"},{"key":"BFpr2016230_CR28","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/pr.2014.108","volume":"76","author":"L Padrini","year":"2014","unstructured":"Padrini L, Isacchi B, Bilia AR, et al. Pharmacokinetics and local safety profile of propranolol eye drops in rabbits. Pediatr Res 2014;76:378\u201385.","journal-title":"Pediatr Res"},{"key":"BFpr2016230_CR29","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1542\/peds.2012-2996","volume":"131","author":"WM Fierson","year":"2013","unstructured":"Fierson WM ; American Academy of Pediatrics Section on Ophthalmology; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus; American Association of Certified Orthoptists. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2013;131:189\u201395.","journal-title":"Pediatrics"},{"key":"BFpr2016230_CR30","first-page":"233","volume":"102","author":"WV Good","year":"2004","unstructured":"Good WV ; Early Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc 2004;102:233\u201348; discussion 248\u201350.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"BFpr2016230_CR31","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/S0095-5108(18)30030-7","volume":"26","author":"P Nuntnarumit","year":"1999","unstructured":"Nuntnarumit P, Yang W, Bada-Ellzey HS. Blood pressure measurements in the newborn. Clin Perinatol 1999;26:981\u201396, x.","journal-title":"Clin Perinatol"},{"key":"BFpr2016230_CR32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jpba.2013.01.034","volume":"78-79","author":"ML Della Bona","year":"2013","unstructured":"Della Bona ML, Malvagia S, Villanelli F, et al. A rapid liquid chromatography tandem mass spectrometry-based method for measuring propranolol on dried blood spots. J Pharm Biomed Anal 2013;78-79:34\u20138.","journal-title":"J Pharm Biomed Anal"},{"key":"BFpr2016230_CR33","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3109\/14767058.2012.755169","volume":"26","author":"L Filippi","year":"2013","unstructured":"Filippi L, Cavallaro G, Fiorini P, et al. Propranolol concentrations after oral administration in term and preterm neonates. J Matern Fetal Neonatal Med 2013;26:833\u201340.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"BFpr2016230_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","volume":"10","author":"R Simon","year":"1989","unstructured":"Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials 1989;10:1\u201310.","journal-title":"Control Clin Trials"},{"key":"BFpr2016230_CR35","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1056\/NEJMc0708819","volume":"358","author":"C L\u00e9aut\u00e9-Labr\u00e8ze","year":"2008","unstructured":"L\u00e9aut\u00e9-Labr\u00e8ze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Ta\u00efeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358:2649\u201351.","journal-title":"N Engl J Med"},{"key":"BFpr2016230_CR36","doi-asserted-by":"publisher","first-page":"e484","DOI":"10.1542\/peds.2007-0803","volume":"123","author":"V Praveen","year":"2009","unstructured":"Praveen V, Vidavalur R, Rosenkrantz TS, Hussain N. Infantile hemangiomas and retinopathy of prematurity: possible association. Pediatrics 2009;123:e484\u20139.","journal-title":"Pediatrics"},{"key":"BFpr2016230_CR37","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/med.21336","volume":"35","author":"L Filippi","year":"2015","unstructured":"Filippi L, Dal Monte M, Casini G, Daniotti M, Sereni F, Bagnoli P. Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the \u03b2-adrenergic system. Med Res Rev 2015;35:619\u201352.","journal-title":"Med Res Rev"},{"key":"BFpr2016230_CR38","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1001\/archopht.1980.01020030114010","volume":"98","author":"RR File","year":"1980","unstructured":"File RR, Patton TF. Topically applied pilocarpine. Human pupillary response as a function of drop size. Arch Ophthalmol 1980;98:112\u20135.","journal-title":"Arch Ophthalmol"},{"key":"BFpr2016230_CR39","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1600-0420.1997.tb00119.x","volume":"75","author":"O Elibol","year":"1997","unstructured":"Elibol O, Al\u00e7elik T, Y\u00fcksel N, Caglar Y. The influence of drop size of cyclopentolate, phenylephrine and tropicamide on pupil dilatation and systemic side effects in infants. Acta Ophthalmol Scand 1997;75:178\u201380.","journal-title":"Acta Ophthalmol Scand"},{"key":"BFpr2016230_CR40","doi-asserted-by":"publisher","first-page":"192","DOI":"10.4103\/2231-4040.85540","volume":"2","author":"S Kumar","year":"2011","unstructured":"Kumar S, Karki R, Meena M, Prakash T, Rajeswari T, Goli D. Reduction in drop size of ophthalmic topical drop preparations and the impact of treatment. J Adv Pharm Technol Res 2011;2:192\u20134.","journal-title":"J Adv Pharm Technol Res"},{"key":"BFpr2016230_CR41","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0039-6257(82)90081-9","volume":"26","author":"JW Shell","year":"1982","unstructured":"Shell JW. Pharmacokinetics of topically applied ophthalmic drugs. Surv Ophthalmol 1982;26:207\u201318.","journal-title":"Surv Ophthalmol"},{"key":"BFpr2016230_CR42","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00210-012-0828-x","volume":"386","author":"M Dal Monte","year":"2013","unstructured":"Dal Monte M, Filippi L, Bagnoli P. Beta3-adrenergic receptors modulate vascular endothelial growth factor release in response to hypoxia through the nitric oxide pathway in mouse retinal explants. Naunyn Schmiedebergs Arch Pharmacol 2013;386:269\u201378.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"BFpr2016230_CR43","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1001\/archopht.130.1.117","volume":"130","author":"WV Good","year":"2012","unstructured":"Good WV, Hardy RJ, Wallace DK, et al. \u03b2-Blocking and racial variation in the severity of retinopathy of prematurity. Arch Ophthalmol 2012;130:117\u20138.","journal-title":"Arch Ophthalmol"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/pr2016230.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr2016230","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr2016230.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:01:26Z","timestamp":1684616486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pr2016230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,4]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["BFpr2016230"],"URL":"https:\/\/doi.org\/10.1038\/pr.2016.230","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,4]]},"assertion":[{"value":"27 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}